By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
GoodRx Holdings, Inc. the people running the company have only been selling lately: three insiders unloaded about $9.8 million of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
On the institutional side, 162 funds reported holding GDRX at the end of Q2 2026, and funds were split between buying and selling. Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
Are insiders buying or selling GDRX stock?
In the last 12 months GoodRx Holdings, Inc. insiders made open-market purchases worth about $0 and sales worth about $9.8 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in GDRX?
The most recent open-market insider trade in GDRX was filed on 2026-08-26.
How many institutions own GDRX?
162 investment managers reported holding GDRX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded GDRX?
No congressional trades in GDRX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).